BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jabir NR, Rehman MT, Alsolami K, Shakil S, Zughaibi TA, Alserihi RF, Khan MS, AlAjmi MF, Tabrez S. Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment. Ann Med 2021;53:2332-44. [PMID: 34889159 DOI: 10.1080/07853890.2021.2009124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoque M, Samanta A, Alam SSM, Zughaibi TA, Kamal MA, Tabrez S. Nanomedicine-based immunotherapy for Alzheimer's Disease. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104973] [Reference Citation Analysis]
2 Oliyaei N, Moosavi-nasab M, Tanideh N, Iraji A. Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights. Brain Research Bulletin 2022. [DOI: 10.1016/j.brainresbull.2022.11.018] [Reference Citation Analysis]
3 Lv S, Dai W, Zheng Y, Dong P, Yu Y, Zhao Y, Sun S, Bi D, Liu C, Han F, Wu J, Zhao T, Ma Y, Zheng F, Sun P. Anxiolytic effect of YangshenDingzhi granules: Integrated network pharmacology and hippocampal metabolomics. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.966218] [Reference Citation Analysis]
4 Shakil S, Rizvi SMD, Greig NH. In depth molecular interaction analyses of the complex of a proposed CTXM-inhibitor bound to the bacterial enzyme. J Biomol Struct Dyn 2022;:1-11. [PMID: 36224195 DOI: 10.1080/07391102.2022.2133009] [Reference Citation Analysis]
5 Zhou F, Huang R, Cao T, Liu J, Yang W, Li F, Li X. 4-Phenylcoumarins from Mesua ferrea with selective CYP1B1 inhibitory activity. Med Chem Res. [DOI: 10.1007/s00044-022-02962-3] [Reference Citation Analysis]
6 Mukerjee N, Das A, Jawarkar RD, Maitra S, Das P, Castrosanto MA, Paul S, Samad A, Zaki MEA, Al-hussain SA, Masand VH, Hasan MM, Bukhari SNA, Perveen A, Alghamdi BS, Alexiou A, Kamal MA, Dey A, Malik S, Bakal RL, Abuzenadah AM, Ghosh A, Md Ashraf G. Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease. Front Aging Neurosci 2022;14:878276. [DOI: 10.3389/fnagi.2022.878276] [Reference Citation Analysis]
7 Lyndem S, Gazi R, Belwal VK, Bhatta A, Jana M, Roy AS. Binding of bioactive esculin and esculetin with hen egg white lysozyme: Spectroscopic and computational methods to comprehensively elucidate the binding affinities, interacting forces, and conformational alterations at molecular level. Journal of Molecular Liquids 2022;360:119423. [DOI: 10.1016/j.molliq.2022.119423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tabrez S, Hoque M, Suhail M, Khan MI, Zughaibi TA, Khan AU. Identification of anticancer bioactive compounds derived from Ficus sp. by targeting Poly[ADP-ribose]polymerase 1 (PARP-1). Journal of King Saud University - Science 2022;34:102079. [DOI: 10.1016/j.jksus.2022.102079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 García Marín ID, Camarillo López RH, Martínez OA, Padilla-martínez II, Correa-basurto J, Rosales-hernández MC. New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease. PLoS ONE 2022;17:e0269129. [DOI: 10.1371/journal.pone.0269129] [Reference Citation Analysis]
10 Nadh AG, Revikumar A, Sudhakaran P, Nair AS. Identification of potential lead compounds against BACE1 through in-silico screening of phytochemicals of Medhya rasayana plants for Alzheimer's disease management. Computers in Biology and Medicine 2022;145:105422. [DOI: 10.1016/j.compbiomed.2022.105422] [Reference Citation Analysis]
11 Khan MS, Althobaiti MS, Almutairi GS, Alokail MS, Altwaijry N, Alenad AM, Al-bagmi MS, Alafaleq NO. Elucidating the binding and inhibitory potential of p-Coumaric acid against amyloid fibrillation and their cytotoxicity: Biophysical and docking analysis. Biophysical Chemistry 2022. [DOI: 10.1016/j.bpc.2022.106823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Abuzenadah AM, Al-Sayes F, Mahafujul Alam SS, Hoque M, Karim S, Hussain IMR, Tabrez S. Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina: Possible Implication in Cancer Therapy. Evid Based Complement Alternat Med 2022;2022:3787162. [PMID: 35368755 DOI: 10.1155/2022/3787162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Abuzenadah AM, Al-Sayes F, Mahafujul Alam SS, Hoque M, Karim S, Hussain IMR, Tabrez S. Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study. Evid Based Complement Alternat Med 2022;2022:6224666. [PMID: 35198035 DOI: 10.1155/2022/6224666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Falade AO, Adewole KE, Ishola AA, Gyebi GA, Olajide NR. Computational studies on the cholinesterase, beta-secretase 1 (BACE1) and monoamine oxidase (MAO) inhibitory activities of endophytes-derived compounds: towards discovery of novel neurotherapeutics. J Biomol Struct Dyn 2022;:1-15. [PMID: 35118932 DOI: 10.1080/07391102.2022.2035255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]